Position in SVRA
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$12,932,932
-$1,517,709 QoQ
Shares Held
2,368,669
-1.2% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
#22
of 184 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SVRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026EMERALD MUTUAL FUND ADVISERS TRUST holds $276,373,005 across 22 Biotechnology names. SVRA ranks #10 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
1,028,832 | $39,599,743 | |
| 2 | TVTX |
Travere Therapeutics, Inc.
|
945,033 | $28,076,930 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
320,211 | $23,778,868 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
250,399 | $23,131,859 | |
| 5 | SYRE |
Spyre Therapeutics, Inc.
|
408,113 | $20,585,219 | |
| 6 | NKTR |
Nektar Therapeutics
|
256,106 | $18,426,826 | |
| 7 | KALV |
KalVista Pharmaceuticals, Inc.
|
805,762 | $16,219,989 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
1,262,492 | $15,061,529 |
All Filings in SVRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,932,932 | 2,368,669 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $14,450,641 | 2,396,458 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $7,680,348 | 2,151,358 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $4,985,001 | 2,186,404 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $5,580,043 | 2,014,456 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $4,223,976 | 1,375,888 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||